Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
Grab Hldgs (NASDAQ:GRAB) reported $228.00 million in sales this quarter. This is a 5.56 percent increase over sales of $216.00 million the same period last year.
Companies Reporting Before The Bell
• Sociedad Quimica Y Minera (NYSE:SQM) is projected to report quarterly earnings at $1.28 per share on revenue of $1.28 billion.